认知诊断市场预测（2025-2030）

认知诊断市场预计将从 2025 年的 1,377.38 亿美元成长到 2030 年的 1,950.61 亿美元，预测期内的复合年增长率为 7.21%。

认知诊断市场涉及专注于认知障碍的评估和诊断的医疗技术。这个市场受到多种因素的推动，包括老年人口的增长、慢性病的流行以及人们对认知能力下降的认识的提高。研究表明，记忆力、执行功能、处理速度和推理等认知功能早在 30 多岁时就会开始下降。此外，研究表明，轻度认知障碍影响 10% 至 20% 的 65 岁以上成年人，并可能发展为更严重的认知问题。与认知功能相关的创新产品和新指标正在进一步推动市场成长。例如，Interaxon的Muse将于2024年9月推出名为Alpha Peak的新型认知功能指数。该指数是一系列领先的大脑健康工具的一部分，透过易于理解的评分系统为使用者提供个人化的见解，以提高他们的认知能力。使用者可以追踪饮食、运动和睡眠等生活方式因素，并将这些因素与他们的 Alpha Peak 分数相关联，以获得优化他们习惯的客製化提示。

市场驱动因素

• 老年人口增加：全球老年人口的增加是认知诊断和治疗需求的主要驱动力。世界卫生组织（WHO）预测，到2030年，每六人中就有一人年龄在60岁或以上，总合约14亿人。到2050年，这一数字预计将达到21亿。老年痴呆症失智症疾病的流行（最常见的失智症）需要正确的诊断和治疗，从而刺激了认知诊断市场的发展。

地理趋势

认知诊断市场分为北美、南美、欧洲、中东和非洲以及亚太等地区。由于医疗保健行业的扩张、人口老化加剧以及对慢性病的日益关注，预计亚太地区将经历显着增长。亚洲开发银行预计，到2050年，亚太地区四分之一的人口将超过60岁，60岁以上人口预计将比2010年增加两倍，达到约13亿。预计中国、日本、韩国和越南等国家将出现快速转型。此外，对忧郁症、失眠症和创伤后压力症候群等疾病的研究不断增加，预计将进一步推动对旨在改善该地区受影响人群生活品质的诊断工具的需求。

为什么要购买这份报告？

• 深刻分析：获得深入的市场洞察，涵盖主要和新兴地区，重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
• 竞争格局：了解全球主要企业所采用的策略策略，并了解正确策略带来的潜在市场渗透率。
• 市场趋势和驱动因素：探索动态因素和关键市场趋势以及它们将如何影响市场的未来发展。
• 可行的建议：利用洞察力做出策略决策，在动态环境中开闢新的业务流和收益。
• 受众广泛：对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途？

产业与市场分析、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

• 2022 年至 2030 年的实际资料和预测
• 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
• 竞争定位、策略与市场占有率分析
• 收益成长和预测包括国家在内的细分市场和地区分析
• 公司概况（策略、产品、财务、主要发展等）

认知诊断市场区隔如下：

按诊断

• 脑部影像检查
• 实验室测试
• 精神状态检查
• 快速居家筛检测试
• 神经心理学测试
• 脑电图 (EEG)
• 认知功能和行为测试
• 神经精神调查问卷

按适应症

• 阿兹海默症
• 注意力不足过动症
• 失智症
• 癫痫相关认知障碍
• 轻度认知功能障碍
• 帕金森氏症相关认知障碍
• 中风相关认知障碍
• 创伤性脑损伤
• 其他的

按最终用户

• 医院
• 神经科诊所
• 认知行为疗法中心
• 復健中心
• 学术和研究机构
• 诊断影像中心
• 其他的

按地区

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 南美洲
• 巴西
• 阿根廷
• 其他的
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 西班牙
• 其他的
• 中东和非洲
• 沙乌地阿拉伯
• UAE
• 以色列
• 其他的
• 亚太地区
• 中国
• 印度
• 日本
• 韩国
• 台湾
• 泰国
• 印尼
• 其他的

目录

第 1 章 简介

• 市场概况
• 市场定义
• 研究范围
• 市场区隔
• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要利益

第二章调查方法

• 研究设计
• 研究过程
• 资料检验

第三章执行摘要

• 主要发现
• 分析师观点

第四章 市场动态

• 市场驱动因素
• 市场限制
• 波特五力分析
• 产业价值链分析

第 5 章 认知诊断市场（依诊断）

• 介绍
• 脑部影像检查
• 实验室测试
• 精神状态检查
• 快速居家筛检测试
• 神经心理学测试
• 脑电图 (EEG)
• 认知功能和行为测试
• 神经精神调查问卷

第六章 认知诊断市场（依适应症划分）

• 介绍
• 阿兹海默症
• 注意力不足过动症
• 失智
• 癫痫相关认知障碍
• 轻度认知障碍
• 帕金森氏症相关认知障碍
• 中风相关认知障碍
• 创伤性脑损伤
• 其他的

第 7 章 认知诊断市场（依最终使用者）

• 介绍
• 医院
• 神经科诊所
• 认知行为治疗中心
• 復健中心
• 学术研究所
• 诊断影像中心
• 其他的

第 8 章 认知诊断市场（按地区）

• 世界概况
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 英国
  • 德国
  • 法国
  • 义大利
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 以色列
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 台湾
  • 泰国
  • 印尼
  • 其他的

第九章竞争格局及分析

• 主要企业和策略分析
• 新兴企业和市场盈利
• 合併、收购、协议和合作
• 竞争仪錶板

第十章 公司简介

• Cognivue, Inc.
• Cambridge Cognition Ltd.
• Diadem srl
• C2N Diagnostics
• Cogstate Ltd.
• Viz.ai
• Mind Maze
• Neurocare Group AG
• Anderson Diagnostics & Labs.
• Altoida AG
• BrainScope Company Inc.
• Neurotrack Technologies Inc.
• BrainCheck
• Cyclops MedTech Pvt Ltd

The cognitive diagnostics market is projected to grow at a CAGR of 7.21% over the forecast period, increasing from US$137.738 billion in 2025 to US$195.061 billion by 2030.

The cognitive diagnostics market pertains to medical technology focused on assessing and diagnosing cognitive disorders. This market is driven by several factors, including the increasing elderly population, the prevalence of chronic diseases, and heightened awareness of cognitive decline. Research indicates that cognitive functions such as memory, executive functions, processing speed, and reasoning may begin to deteriorate as early as a person's thirties. Additionally, studies show that mild cognitive impairment affects 10-20% of adults over 65, which can progress to more severe cognitive issues.Innovative products and new metrics related to cognitive functions are further propelling market growth. For instance, Muse by Interaxon launched a new cognitive performance metric called Alpha Peak in September 2024. This metric is part of a suite of advanced brain health tools that provide users with personalized insights to enhance cognitive performance through an easy-to-understand scoring system. Users can track lifestyle factors like diet, exercise, and sleep, correlating these with their Alpha Peak score and receiving tailored prompts for habit optimization.

Key Developments

• Strategic Partnerships: In August 2024, Firefly Neuroscience, Inc. announced a strategic partnership with Neurology Consultants of Dallas (NCD) to enhance early detection and disease management for patients experiencing cognitive decline. NCD will integrate Firefly's Brain Network Analytics technology into its workflow and conduct clinical studies.
• Investment in Innovative Testing: In March 2024, C2N Diagnostics, LLC received an investment of up to $15 million from Eisai Inc. This collaboration aims to scale access to their Precivity tests-innovative blood tests designed for patients with cognitive impairment that assist healthcare providers in diagnosing Alzheimer's disease pathology and informing treatment decisions.

Market Drivers

• Growing Geriatric Population: The increasing elderly population globally is a primary driver for the demand for cognitive diagnostics and treatments. The World Health Organization (WHO) projects that by 2030, one in six individuals will be aged 60 or older, totaling approximately 1.4 billion people. By 2050, this number is expected to reach 2.1 billion. The prevalence of diseases like Alzheimer's- the most common form of dementia- necessitates proper diagnostics and treatments, thereby fueling the cognitive diagnostics market.

Geographical Trends

The cognitive diagnostics market is segmented into regions including North America, South America, Europe, the Middle East & Africa, and Asia Pacific. The Asia Pacific region is anticipated to experience significant growth due to its expanding healthcare industry, increasing elderly population, and rising concerns about chronic diseases. According to the Asian Development Bank, by 2050, one in four individuals in Asia and the Pacific will be over 60 years old, with the population aged over 60 expected to triple from 2010 levels to nearly 1.3 billion. Rapid transitions are anticipated in countries such as China, Japan, South Korea, and Vietnam. Additionally, growing research into conditions like depression, insomnia, and PTSD will further drive demand for diagnostic tools aimed at improving quality of life for affected individuals in this region.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

Cognitive diagnostics market has been segmented as following:

By Diagnosis

• Brain Imaging Tests
• Laboratory Testing
• Mental Status Testing
• Rapid Home Screening Tests
• Neuropsychological Testing
• Electroencephalogram (EEG)
• Cognitive Function And Behavioral Tests
• Neuropsychiatric Inventory Questionnaire

By Indication

• Alzheimer's Disease
• Attention Deficit / Hyperactivity Disorder
• Dementia
• Epilepsy-Related Cognitive Dysfunction
• Mild Cognitive Impairment
• Parkinson's Disease-Related Cognitive Dysfunction
• Stroke-Related Cognitive Dysfunction
• Traumatic Brain Injury
• Others

By End User

• Hospitals
• Neurology Clinics
• Cognitive Behavioral Therapy Centers
• Rehabilitation Centers
• Academic And Research Institutes
• Diagnostic Imaging Centers
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Italy
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Taiwan
• Thailand
• Indonesia
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Process
• 2.3. Data Validation

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. Analyst View

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Supplier
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis

5. COGNITIVE DIAGNOSTICS MARKET BY DIAGNOSIS

• 5.1. Introduction
• 5.2. Brain Imaging Tests
• 5.3. Laboratory Testing
• 5.4. Mental Status Testing
• 5.5. Rapid Home Screening Tests
• 5.6. Neuropsychological Testing
• 5.7. Electroencephalogram (EEG)
• 5.8. Cognitive Function And Behavioral Tests
• 5.9. Neuropsychiatric Inventory Questionnaire

6. COGNITIVE DIAGNOSTICS MARKET BY INDICATION

• 6.1. Introduction
• 6.2. Alzheimer's Disease
• 6.3. Attention Deficit / Hyperactivity Disorder
• 6.4. Dementia
• 6.5. Epilepsy-Related Cognitive Dysfunction
• 6.6. Mild Cognitive Impairment
• 6.7. Parkinson's Disease-Related Cognitive Dysfunction
• 6.8. Stroke-Related Cognitive Dysfunction
• 6.9. Traumatic Brain Injury
• 6.10. Others

7. COGNITIVE DIAGNOSTICS MARKET BY END USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Neurology Clinics
• 7.4. Cognitive Behavioral Therapy Centers
• 7.5. Rehabilitation Centers
• 7.6. Academic And Research Institutes
• 7.7. Diagnostic Imaging Centers
• 7.8. Others

8. COGNITIVE DIAGNOSTICS MARKET BY GEOGRAPHY

• 8.1. Global Overview
• 8.2. North America
  • 8.2.1. United States
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. United Kingdom
  • 8.4.2. Germany
  • 8.4.3. France
  • 8.4.4. Italy
  • 8.4.5. Spain
  • 8.4.6. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia-Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Taiwan
  • 8.6.6. Thailand
  • 8.6.7. Indonesia
  • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Emerging Players and Market Lucrativeness
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Cognivue, Inc.
• 10.2. Cambridge Cognition Ltd.
• 10.3. Diadem srl
• 10.4. C2N Diagnostics
• 10.5. Cogstate Ltd.
• 10.6. Viz.ai
• 10.7. Mind Maze
• 10.8. Neurocare Group AG
• 10.9. Anderson Diagnostics & Labs.
• 10.10. Altoida AG
• 10.11. BrainScope Company Inc.
• 10.12. Neurotrack Technologies Inc.
• 10.13. BrainCheck
• 10.14. Cyclops MedTech Pvt Ltd